Michael Nehil. Genetic Editing of iNK Cell Therapies to Enhance Tumor Killing Capacity. Presented at The iPSC-Derived Immunotherapies Congress 2022. October 19, 2022.

Aug

28

Editas Medicine to Participate in Upcoming Investor Conferences

Aug

7

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

Jul

31

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update